Sunopta, Inc’s recently made public that its SVP R&D and QA Clark Bryan P unloaded Company’s shares for reported $45212.0 on Mar 13 ’25. In the deal valued at $5.32 per share,8,500 shares were sold. As a result of this transaction, Clark Bryan P now holds 28,150 shares worth roughly $0.18 million.
Then, BRYAN CLARK bought 8,500 shares, generating $45,212 in total proceeds.
Before that, CHAD M HAGEN bought 39,527 shares. Sunopta, Inc shares valued at $245,222 were divested by the Officer at a price of $6.20 per share.
DA Davidson initiated its Sunopta, Inc [STKL] rating to a Buy in a research note published on December 08, 2023; the price target was $8. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. Stephens began covering STKL with “an Overweight” recommendation on June 23, 2023. Cowen started covering the stock on September 10, 2021. It rated STKL as “an Outperform”.
Price Performance Review of STKL
On Tuesday, Sunopta, Inc [NASDAQ:STKL] saw its stock fall -2.02% to $6.31. Over the last five days, the stock has gained 32.84%. Sunopta, Inc shares have fallen nearly -18.05% since the year began. Nevertheless, the stocks have risen 7.68% over the past one year. While a 52-week high of $8.11 was reached on 01/02/25, a 52-week low of $3.64 was recorded on 04/10/25. SMA at 50 days reached $4.84, while 200 days put it at $6.32.
Levels Of Support And Resistance For STKL Stock
The 24-hour chart illustrates a support level at 6.23, which if violated will result in even more drops to 6.15. On the upside, there is a resistance level at 6.45. A further resistance level may holdings at 6.60. The Relative Strength Index (RSI) on the 14-day chart is 73.37, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.37, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.13%. Stochastics %K at 84.32% indicates the stock is a selling.
The most recent change occurred on July 09, 2021 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $15 price target.
